Compounds which selectively modulate the CB2 receptor
申请人:Bartolozzi Alessandra
公开号:US08372874B2
公开(公告)日:2013-02-12
Compounds of formula (I)
are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
Sulfonyl compounds which selectively modulate the CB2 receptor
申请人:Boehringer Ingelheim International GmbH
公开号:EP2342199B1
公开(公告)日:2014-02-26
COMPOUNDS WHICH SELECTIVELY MODULATE THE CB2 RECEPTOR
申请人:Boehringer Ingelheim International GmbH
公开号:EP2342199A2
公开(公告)日:2011-07-13
Tetrazole Compounds Which Selectively Modulate The CB2 Receptor
申请人:ERMANN Monika
公开号:US20120071529A1
公开(公告)日:2012-03-22
Compounds of formula (I)
are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.